UK Earnings, Trading Statements Calendar | |
Tuesday, February 3 | |
BG Group | Full Year Results |
BP | Full Year Results |
Ocado Group | Full Year Results |
Creston | Interim Management Statement |
Aberdeen Asset Management | Q1 Trading Statement |
Alumasc Group | Half Year Results |
Low & Bonar | Full Year Results |
St Modwen Property | Full Year Results |
TalkTalk Telecom Group | Interim Management Statement |
UDG Healthcare | Q1 Trading Statement |
Wednesday, February 4 | |
GlaxoSmithKline | Full Year Results |
Hargreaves Lansdown | Half Year Results |
International Consolidated Airlines Group | January Traffic Statistics |
Sky | Half Year Results |
Victrex | Interim Management Statement |
Daily Mail and General Trust | Trading Statement |
GW Pharmaceuticals | Q1 Results |
Thursday, February 5 | |
Fusionex International | Full Year Results |
McBride | Interim Results |
Compass Group | Interim Management Statement |
Beazley | Full Year Results |
AstraZeneca | Full Year Results |
EasyJet | January Traffic Statistics |
Dairy Crest Group | Interim Management Statement |
Future | Interim Management Statement |
Enterprise Inns | Interim Management Statement |
Grainger | Interim Management Statement |
Smith & Nephew | Full Year Results |
Vodafone Group | Interim Management Statement |
Avanti Communications Group | Half Year Results |
Friday, February 6 | |
Shaftesbury | AGM Statement |
Monday, February 9 | |
Randgold Resources | Full Year Results |
Copyright 2015 Alliance News Limited. All Rights Reserved. | |
BUZZ-GW Pharmaceuticals Plc: Drug could have potential in autism - Telegraph
** Cannibis-based drugmaker's U.S.-listed shares up 11.11 pct at $76.29, snapping a three-day streak of declines ** Company putting together "building blocks" of a research program to see if a cannabis-based medicine could treat symptoms of autism, CEO told The Telegraph (http://bit.ly/1pUW
Read more